Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
A phase 2 trial of Obinutuzumab, Glofitamab, Gemcitabine and Oxaliplatin in hodgkin lymphoma, run by Hoffmann-La Roche, now recruiting.
Overview
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL is a phase 2 interventional study registered as NCT06806033 by Hoffmann-La Roche, with 130 participants planned, started 2025-03-05 and due to reach its primary completion in 2027-01-31. Interventions recorded: Obinutuzumab, Glofitamab, Gemcitabine and Oxaliplatin.
Similar pages
not linked directly; found by shared links- TrialAn Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
Shares Glofitamab, Obinutuzumab, Flatiron Health (Roche), Hodgkin lymphoma and the tag pipeline.
- TrialA Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Shares Glofitamab, Obinutuzumab, Flatiron Health (Roche) and the tag pipeline.
- TrialProgrammed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTC
Shares Oxaliplatin, Gemcitabine and the tag pipeline.
- TrialIrinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer
Shares Oxaliplatin, Gemcitabine and the tag pipeline.
- TrialClinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma
Shares Oxaliplatin, Gemcitabine and the tag pipeline.
- TrialA Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Shares Glofitamab, Obinutuzumab and the tag pipeline.
- TrialA Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma
Shares Glofitamab, Flatiron Health (Roche) and the tag pipeline.
- TrialA Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer
Shares Oxaliplatin, Gemcitabine and the tag pipeline.